Published in J Pharm Pharmacol on November 01, 1981
Unsafe activities of compounding pharmacists. Am J Health Syst Pharm (1995) 1.39
Binding of drugs by albumin and plasma protein. J Pharm Sci (1977) 1.31
Determination of two fenamates in plasma by high-performance liquid chromatography. J Pharm Sci (1980) 1.21
Effect of pH on the binding of theophylline to serum proteins. Am Rev Respir Dis (1979) 1.18
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg (1985) 1.01
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm (1986) 0.94
Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet (1984) 0.92
Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. Clin Pharm (1984) 0.92
Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. J Pharm Pharmacol (1986) 0.85
A comparison of the determination of partition coeficients of 1,4-benzodiazephines by high-performance liquid chromatography and thin-layer chromatography. J Chromatogr (1976) 0.85
A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and naproxen to human serum albumin. J Pharm Biomed Anal (1997) 0.84
Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin. J Pharm Sci (1976) 0.83
Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther (1999) 0.83
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
Clearance of serum cortisol in suckled and nonsuckled postpartum beef cows. J Anim Sci (1981) 0.80
Cephalosporins for surgical prophylaxis: computer projections of intraoperative availability. South Med J (1985) 0.80
The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements. J Pharm Pharmacol (1987) 0.80
Intraoperative ceforanide pharmacokinetics and protein binding. Antimicrob Agents Chemother (1985) 0.79
The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication. Pharm Res (1996) 0.79
Penicillin-enhanced chemiluminescence of the luminol-H2O2-Co2+ system. J Pharm Sci (1991) 0.79
Effects of tricyclic drug on induced circular dichroism spectra of dicumarol bound to alpha 1-acid glycoprotein. Biochem Pharmacol (1991) 0.78
Increased luminescence of the tetracycline-europium(III) system following oxidation by hydrogen peroxide. J Pharm Biomed Anal (1999) 0.77
Further investigations into the absorption of dextromethorphan from the rat's stomach. J Pharm Sci (1969) 0.77
Small molecule-macromolecular interactions as studied by optical rotatory dispersion--circular dichroism. J Pharm Sci (1970) 0.77
Circular dichroism and viscometric studies on a basic protein from pig brain. J Neurochem (1971) 0.77
Effect of pH and small inorganic ions on binding of sulfadimethoxine and sulfaphenazole to human serum albumin measured by circular dichroism. Chem Pharm Bull (Tokyo) (1989) 0.77
Effects of drug-binding on the thermal denaturation of human serum albumin. J Pharm Biomed Anal (1994) 0.77
Interaction of dantrolene sodium with human serum albumin. J Pharm Sci (1976) 0.76
Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin. Clin Pharmacol Ther (1984) 0.76
Interfacial tensions and partition coefficients in water/heptane systems containing 2,6-diisopropylphenol, n-alkylphenols and cycloalkanols. J Pharm Pharmacol (1988) 0.76
Hemodialysis of theophylline in uremic patients. J Clin Pharmacol (1979) 0.76
Comments concerning "Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs". J Pharm Sci (1994) 0.75
Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects. J Clin Pharmacol (1980) 0.75
Evaluation of the performance of controlled release dosage forms of ticlopidine using in vitro intestinal permeability and computer simulations. J Drug Target (1994) 0.75
Analysis of some dosage forms containing pyridine derivatives using a cyclodextrin bonded stationary phase in HPLC. J Pharm Biomed Anal (1988) 0.75
Effect of bile salts on partitioning behavior and GI absorption of a quaternary ammonium compound, isopropamide iodide. J Pharm Sci (1973) 0.75
Albumin-binding interactions of sodium valproate. J Clin Pharmacol (1981) 0.75
Acetaminophen-aluminum hydroxide interaction in rabbits. J Pharm Sci (1983) 0.75
Diode array spectroscopy in pharmaceutical analysis: determination of acetaminophen/codeine phosphate tablets. J Pharm Biomed Anal (1989) 0.75
High-performance liquid chromatographic determination of conjugated estrogens in tablets. J Chromatogr (1988) 0.75
Binding of xanthine derivatives to human serum albumin as a function of pH. Acta Pharm Suec (1981) 0.75
Mechanism for phenothiazine oxidation. J Pharm Sci (1977) 0.75
Viscosity of phosphatidylcholine (lecithin). J Pharm Pharmacol (1966) 0.75
Variation in the heats of reaction of drugs and albumin with the source and pretreatment of the albumin. J Pharm Pharmacol (1979) 0.75
Quantitative correlations between albumin binding constants and chromatographic Rm values of phenothiazine derivatives. J Med Chem (1977) 0.75
A new method for the determination of the site binding constant of each species of a partially ionized drug. Acta Pharm Suec (1980) 0.75
Influence of respiratory acidosis and alkalosis on volume of distribution of theophylline in dogs. Res Commun Chem Pathol Pharmacol (1979) 0.75
Improved high-performance liquid chromatographic assay for cimetidine using ranitidine as an internal standard. J Chromatogr (1982) 0.75
An unbiased method for estimating binding parameters in a non-cooperative binding process. Biochim Biophys Acta (1974) 0.75
The interaction of some coumarin anticoagulants with beta-cyclodextrin in phosphate buffers. Pharm Acta Helv (1978) 0.75
Aggregation of dantrolene to human serum albumin. J Pharm Sci (1978) 0.75
beta-Lipoproteins: possible plasma transport proteins for basic drugs. J Pharm Sci (1977) 0.75
A microcalorimetric investigation of the binding of flurbiprofen to cyclodextrins. J Pharm Biomed Anal (1986) 0.75
Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin. Biochem Pharmacol (1975) 0.75
Liquid chromatography in pharmaceutical analysis VI: determination of dantrolene sodium in a dosage form. J Pharm Sci (1977) 0.75
Plasma level profiles and clinical response of penbutolol after three different single oral doses in man. J Clin Pharmacol (1979) 0.75
Cardiac rhythm disturbances during fiberoptic bronchoscopy: a prospective study. J Thorac Cardiovasc Surg (1979) 0.75
Bioavailability of regular and controlled-release chlorpheniramine products. J Pharm Sci (1982) 0.75
Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin. J Pharm Sci (1982) 0.75
Measurement of flurbiprofen-human serum albumin interaction by fluorimetry. J Pharm Biomed Anal (1985) 0.75
Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry. Am J Hosp Pharm (1988) 0.75
Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements. Biochim Biophys Acta (1979) 0.75
High-performance liquid chromatography assay for fenbufen and two serum metabolites. J Chromatogr (1982) 0.75
The effect of Ca++ on the binding of drugs to human serum albumin: pharmacokinetic implications. Biopharm Drug Dispos (1983) 0.75
Liquid chromatographic assay of phenothiazine, thioxanthene and butyrophenone neuroleptics and antihistamines in blood and plasma with conventional and radial compression columns and UV and electrochemical detection. J Chromatogr (1982) 0.75
Some novel observations of a drug (indoprofen)--albumin interaction. Biopharm Drug Dispos (1983) 0.75
Microcalorimetric investigations of pharmaceutical complexes. I. Drugs and beta-cyclodextrin. Acta Pharm Suec (1978) 0.75
A fluorimetric investigation of the binding of drugs to lysozyme. J Pharm Pharmacol (1981) 0.75
The absorption and distribution of isopropamide iodide in the rat. J Pharm Pharmacol (1973) 0.75
Microcalorimetric and chromatographic investigations of the binding of some pyridine derivatives to cyclodextrins. J Pharm Biomed Anal (1988) 0.75
Disastrous reflavorig of antibiotics. Pediatrics (1997) 0.75
Indomethacin release from silicone rubber: a suggested method for continuous inhibition of prostaglandin synthesis. Res Commun Chem Pathol Pharmacol (1975) 0.75
Examination of blood clobazam levels and several pupillary measures in humans. J Pharm Sci (1979) 0.75
Binding of piroxicam to human serum albumin: effect of piroxicam on warfarin and diazepam binding. Pharm Res (1987) 0.75
Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations. Biopharm Drug Dispos (1982) 0.75
Postcolumn chemiluminescence as a detection technique in the liquid chromatographic analysis of beta-lactam ring containing compounds. Biomed Chromatogr (1997) 0.75
Oxidation kinetics of phenothiazine and 10-methylphenothiazine in acidic medium. J Pharm Sci (1977) 0.75
beta-Cyclodextrin as an aid to peritoneal dialysis. Renal toxicity of beta-cyclodextrin in the rat. Res Commun Chem Pathol Pharmacol (1978) 0.75
The interaction of dopexamine with various drugs and excipients in parenteral solutions. J Pharm Pharmacol (1988) 0.75
Human plasma levels of propranolol: fluorometric measurement in a hydrosolvatic system. J Pharm Sci (1980) 0.75
Observations of conformational changes in human serum albumin following removal of fatty acid by charcoal. J Pharm Biomed Anal (1991) 0.75
Preliminary investigations of intrinsic and extrinsic optical activity as purity criterion for human serum albumins. J Pharm Sci (1975) 0.75
Scatchard plot analysis of ligand--erythrocyte interactions. J Pharm Sci (1978) 0.75
Microcalorimetric investigations of drug-albumin interactions. Biopharm Drug Dispos (1985) 0.75
Effect of bile salts on partitioning and oral toxicity of the bisquaternary ammonium drug decamethonium bromide. J Pharm Sci (1974) 0.75
Circular dichroic investigations of the binding of salicylate and related compounds to human serum albumin. Biochem Pharmacol (1977) 0.75
Freezing of suspensions. Am J Hosp Pharm (1979) 0.75
Absorption and disposition of ethambutol in rabbits. J Pharm Sci (1984) 0.75
The effect of the anion on the absorption of tetracycline from the rat stomach. J Pharm Pharmacol (1970) 0.75
Liquid chromatography in pharmaceutical analysis VII: determination of dantrolene sodium in biological fluids. J Pharm Sci (1977) 0.75
Microcalorimetric investigations of pharmaceutical complexes II. Drug-albumin interactions. Biochem Pharmacol (1978) 0.75
A microcalorimetric investigation of the binding of cinnarizine to cyclodextrins. J Pharm Biomed Anal (1989) 0.75
Dynamic dialysis in drug-erythrocyte interactions. J Pharm Sci (1979) 0.75
Interaction of sulindac and metabolite with human serum albumin. J Pharm Sci (1978) 0.75
Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy. J Pharm Pharmacol (1980) 0.75
Interaction of the antimalarial alpha-dibutylaminomethyl-2,6-bis(trifluoromethylphenyl)-4-pyridinemethanol with human serum albumin. J Pharm Sci (1979) 0.75